{
  "zip": "20850",
  "sector": "Healthcare",
  "fullTimeEmployees": 3,
  "longBusinessSummary": "RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. It is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was founded in 1982 and is based in Rockville, Maryland.",
  "city": "Rockville",
  "phone": "301 208 9191",
  "state": "MD",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.regenerx.com",
  "maxAge": 1,
  "address1": "15245 Shady Grove Road",
  "industry": "Biotechnology",
  "address2": "Suite 470",
  "previousClose": 0.49,
  "regularMarketOpen": 0.46,
  "twoHundredDayAverage": 0.49230215,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.49,
  "navPrice": null,
  "averageDailyVolume10Day": 92962,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.49,
  "fiftyDayAverage": 0.50545454,
  "trailingAnnualDividendRate": null,
  "open": 0.46,
  "averageVolume10days": 92962,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.024684,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.46,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 8880,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 64052160,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 83334,
  "priceToSalesTrailing12Months": 834.42535,
  "dayLow": 0.46,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 8880,
  "fiftyTwoWeekHigh": 0.75,
  "forwardPE": -48,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.15,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.49,
  "exchange": "PNK",
  "shortName": "REGENERX BIOPHARMACEUTICALS",
  "longName": "RegeneRx Biopharmaceuticals, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "RGRX",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_249088",
  "uuid": "7034c491-202d-3f1c-83a2-d573e7eb0106",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 844.962,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -49.765,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": -0.01,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 133442000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.022,
  "sharesShort": 19190,
  "sharesPercentSharesOut": 0.00029999999,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.00176,
  "netIncomeToCommon": -1504934,
  "trailingEps": -0.011,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.48264,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": 0.15,
  "sharesShortPreviousMonthDate": 1288310400,
  "floatShares": 103879094,
  "enterpriseValue": 64860940,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1291075200,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0005,
  "sharesShortPriorMonth": 29317,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.46,
  "logo_url": "https://logo.clearbit.com/regenerx.com"
}